These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26806507)

  • 1. Novel effect of rapamycin on experimental obliterative bronchiolitis.
    Walters DM; Mulligan MS
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):317-8. PubMed ID: 26806507
    [No Abstract]   [Full Text] [Related]  

  • 2. Harnessing regulatory B cells to prevent experimental obliterative bronchiolitis.
    Jungraithmayr W; Brüstle K; Weder W
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):497-8. PubMed ID: 26520010
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion.
    Pham SM
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):496. PubMed ID: 26481283
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapamycin prevents bronchiolitis obliterans through increasing infiltration of regulatory B cells in a murine tracheal transplantation model.
    Zhao Y; Gillen JR; Meher AK; Burns JA; Kron IL; Lau CL
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):487-96.e3. PubMed ID: 26481278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obliterative bronchiolitis: prevention.
    Kallio EA; Koskinen PK; Tikkanen JM; Lemström KB
    Transplant Proc; 2001; 33(1-2):1617-9. PubMed ID: 11267443
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: leukocyte trafficking and matrix metalloproteinase-8 in obliterative bronchiolitis.
    Grasemann H; Ratjen F
    J Leukoc Biol; 2010 Jan; 87(1):23-4. PubMed ID: 20047888
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of complement reduces obliterative bronchiolitis.
    Kallio E; Lemström K; Ryan U; Häyry P; Koskinen P
    Transplant Proc; 1999; 31(1-2):188. PubMed ID: 10083071
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
    Morris RE; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse R; Berry GJ
    Transplant Proc; 1995 Jun; 27(3):2068-9. PubMed ID: 7792888
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor.
    Kallio E; Koskinen P; Buchdunger E; Lemström K
    Transplant Proc; 1999; 31(1-2):187. PubMed ID: 10083070
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas.
    Qu N; de Vos P; Schelfhorst M; de Haan A; Timens W; Prop J
    J Heart Lung Transplant; 2005 Jul; 24(7):882-90. PubMed ID: 15982618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of obliterative bronchiolitis. Possible roles of platelet-derived growth factor and basic fibroblast growth factor.
    al-Dossari GA; Jessurun J; Bolman RM; Kshettry VR; King MB; Murray JJ; Hertz MI
    Transplantation; 1995 Jan; 59(1):143-5. PubMed ID: 7839417
    [No Abstract]   [Full Text] [Related]  

  • 12. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
    Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
    Krebs R; Tikkanen JM; Ropponen JO; Jeltsch M; Jokinen JJ; Ylä-Herttuala S; Nykänen AI; Lemström KB
    Am J Pathol; 2012 Nov; 181(5):1607-20. PubMed ID: 22959907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel reduces post-transplant obliterative bronchiolitis.
    Preidl RH; Eckl S; Ramsperger-Gleixner M; Koch N; Spriewald BM; Weyand M; Ensminger SM
    Transpl Int; 2013 Oct; 26(10):1038-48. PubMed ID: 23952051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 superagonist antibody treatment attenuated obliterative bronchiolitis in rat allo-orthotopic tracheal transplantation by preferentially expanding Foxp3-expressing regulatory T cells.
    Shi Q; Niu Y; Cao H; Zhou X; Jiang S; Liu Z; Fan H
    Transplant Proc; 2012 May; 44(4):1060-6. PubMed ID: 22564625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ Foxp3+ regulatory T cells induced by TGF-β, IL-2 and all-trans retinoic acid attenuate obliterative bronchiolitis in rat trachea transplantation.
    Shi Q; Cao H; Liu J; Zhou X; Lan Q; Zheng S; Liu Z; Li Q; Fan H
    Int Immunopharmacol; 2011 Nov; 11(11):1887-94. PubMed ID: 21839859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obliterative airway disease after heterotopic tracheal xenotransplantation in a concordant rodent model: pathogenesis and treatment.
    Reichenspurner H; Adams B; Soni V; Brazelton T; Shorthouse R; Reitz BA; Berry GJ; Morris RE
    Transplant Proc; 1996 Apr; 28(2):729-30. PubMed ID: 8623368
    [No Abstract]   [Full Text] [Related]  

  • 19. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
    Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
    Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis.
    Visner GA; Lu F; Zhou H; Latham C; Agarwal A; Zander DS
    Transplantation; 2003 Aug; 76(4):650-6. PubMed ID: 12973103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.